Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Arch Pharm Res ; 31(1): 47-53, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18277607

RESUMO

Radix Salviae miltiorrhiza (RSM, 'Dansham' in Korea, 'Danshen' in Chinese), the root of Salviae miltiorrhiza Bunge (Labiate) has been used as Chinese fork medicine for the treatment of cardiovascular diseases such as angina pectoris, coronary heart disease, myocardial infarction, and hypertension. In the present study, we evaluated the inhibitory effects of 15,16-Dihydrotanshinone I, one of the major ingredients of Salvia miltiorrhiza Bunge, on platelet aggregation, with elucidation of its mechanisms of action. 15,16-Dihydrotanshinone I concentration-dependently inhibited collagen-induced aggregation of rabbit washed platelets with IC50 of 8.7+/-5.6 microM, the potency being about seven-fold greater than EGCG, an active Green tea catechin component (IC50: 56.6+/-48.7 microM). 15,16-Dihydrotanshinone I significantly inhibited the intracellular calcium ([Ca2+]i) mobilization in a concentration-dependent manner. 15,16-dihdydrotanshinone I also significantly suppressed collagen (50 microg/mL)-induced liberation of [3H]Arachidonic acid from [3H]Arachidonic acid-incorporated rabbit platelet. In addition, 15,16-Dihydrotanshinone I at 50 microM slightly but significantly inhibited collagen-induced production of thromboxane B2. These results indicate that 15,16-Dihydrotanshinone I exert potent anti-platelet activity via suppression of [Ca2+]i mobilization and arachidonic acid liberation.


Assuntos
Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Cálcio/sangue , Fenantrenos/farmacologia , Inibidores da Agregação Plaquetária , Agregação Plaquetária/efeitos dos fármacos , Salvia/química , Animais , Ácido Araquidônico/sangue , Colágeno/farmacologia , Citosol/efeitos dos fármacos , Citosol/metabolismo , Furanos , Técnicas In Vitro , Fenantrenos/isolamento & purificação , Quinonas , Coelhos , Trombina/farmacologia , Tromboxano B2/sangue
2.
Meat Sci ; 78(4): 455-60, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22062465

RESUMO

We compared differentially expressed genes and muscle fiber types in the longissimus muscles of Korean native pigs (KNP) and the western meat-producing breeds Landrace and Yorkshire. The KNP breed exhibited a higher muscle fat content and more red meat color as determined by the a(∗) (redness) value (P<0.01) and b(∗) (yellowness) value (P<0.05) compared to the western breeds. Using differential display RT-PCR, we detected two genes that were differentially expressed in skeletal muscle among the pig breeds. These genes were identified as NADH dehydrogenase subunit 1 and ATPase subunit 6 by cloning and sequencing analysis. Both of these genes are involved oxidative phosphorylation and therefore energy metabolism. The genes were more highly expressed in the KNP breed than in the other breeds, indicating that KNPs exhibit more oxidative metabolism than do the western breeds. We also analyzed the mRNA levels of myosin heavy-chain isoforms such as type I (oxidative), type IIb (glycolytic), and types IIa and IIx (intermediate) fibers using real-time RT-PCR. The mRNA levels of oxidative and intermediate fibers were elevated in the KNP breed, whereas the glycolytic fibers were more highly expressed in the Landrace and Yorkshire pigs. These results suggest that the elevated expression of the oxidation-related metabolism genes NADH dehydrogenase and ATPase is related to meat quality as indicated by a higher content of oxidative fibers and muscle fat, as well as redder meat color.

3.
Arch Pharm Res ; 30(5): 634-40, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17615684

RESUMO

To investigate the involvement of reperfusion-induced salvage kinases (RISK) as possible signaling molecules for the cardioprotective effects of BMS-180448, a prototype mitochondrial ATP-sensitive K+ (mitoK(ATP)) channel opener, we measured its cardioprotective effects in a rat model of ischemia/reperfusion (I/R) heart injury, together with western blotting analysis of five different signaling proteins. In isolated rat hearts subjected to 30-min global ischemia followed by 30-min reperfusion, BMS-180448 (1, 3 and 10 microM) significantly increased reperfusion left ventricular developed pressure (LVDP) and 30-min reperfusion double product (heart rate x LVDP) in a concentration-dependent manner, while decreasing left ventricular end-diastolic pressure (LVEDP) throughout reperfusion period in a concentration-dependent manner. SDS-PAGE/western blotting analysis of left ventricle reperfused for 30 min revealed that BMS-180448 significantly decreased phospho-GSK3beta at high concentration, whereas it tended to increase slightly phospho-eNOS and phospho-p70S6K with concentration. However, BMS-180448 had no effect on phospho-Akt and phospho-Bad. These results suggest that the cardioprotective effects of BMS-180448 against I/R heart injury may result from direct activation of mitoK(ATP) channel in cardiomyocytes, with the minimal role of RISK pathway in the activation of this channel and the cardioprotective effects of BMS-180448.


Assuntos
Benzopiranos/farmacologia , Guanidinas/farmacologia , Traumatismo por Reperfusão Miocárdica/prevenção & controle , Canais de Potássio/efeitos dos fármacos , Proteínas Quinases S6 Ribossômicas 70-kDa/fisiologia , Animais , Relação Dose-Resposta a Droga , Quinase 3 da Glicogênio Sintase/metabolismo , Glicogênio Sintase Quinase 3 beta , Masculino , Óxido Nítrico Sintase Tipo III/metabolismo , Fosfatidilinositol 3-Quinases/fisiologia , Fosforilação , Ratos , Ratos Sprague-Dawley , Função Ventricular Esquerda/efeitos dos fármacos
4.
Antimicrob Agents Chemother ; 47(12): 3704-7, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14638469

RESUMO

The effects of moxifloxacin, a new methoxyfluoroquinolone, on the production of proinflammatory cytokines from human peripheral blood mononuclear cells (PBMCs) were evaluated. Moxifloxacin inhibited the production of tumor necrosis factor alpha (TNF-alpha) and/or interleukin-6 (IL-6) by PBMCs stimulated with lipopolysaccharide (LPS), lipoteichoic acid (LTA), and heat-killed bacteria in a concentration-dependent manner without cytotoxic effects. The addition of moxifloxacin reduced the population of cells positive for CD-14 and TNF-alpha and for CD-14 and IL-6 among the LPS- or LTA-stimulated PBMCs. By Western blot analysis, moxifloxacin pretreatment reduced the degradation of IkappaBalpha in LPS-stimulated PBMCs. In conclusion, moxifloxacin could interfere with NF-kappaB activation by inhibiting the degradation of IkappaBalpha and reduce the levels of production of proinflammatory cytokines.


Assuntos
Anti-Infecciosos/farmacologia , Compostos Aza/farmacologia , Citocinas/biossíntese , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , Quinolinas/farmacologia , Adjuvantes Imunológicos/farmacologia , Western Blotting , Ceftriaxona/farmacologia , Sobrevivência Celular , Cefalosporinas/farmacologia , Ensaio de Imunoadsorção Enzimática , Escherichia coli/imunologia , Citometria de Fluxo , Fluoroquinolonas , Humanos , Proteínas I-kappa B/metabolismo , Técnicas In Vitro , Interleucina-6/biossíntese , Receptores de Lipopolissacarídeos/metabolismo , Moxifloxacina , Ofloxacino/farmacologia , Streptococcus pneumoniae/imunologia , Fator de Necrose Tumoral alfa/biossíntese
5.
Antimicrob Agents Chemother ; 47(3): 1161-4, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12604563

RESUMO

Ciprofloxacin (CPFX) and roxithromycin (RXM) induced apoptosis of activated Jurkat T cells in vitro. CPFX showed concentration-dependent acceleration of apoptosis of activated Jurkat T cells by enhancing the expression of FasL and activities of caspase-3 and -8. RXM accelerated cell death, enhanced expression of FasL and caspase-3 but not caspase-8, and did not show the concentration dependency.


Assuntos
Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Apoptose/efeitos dos fármacos , Ciprofloxacina/farmacologia , Proteínas Proto-Oncogênicas c-bcl-2 , Roxitromicina/farmacologia , Linfócitos T/efeitos dos fármacos , Caspases/biossíntese , Sobrevivência Celular/efeitos dos fármacos , Fragmentação do DNA , Ensaio de Imunoadsorção Enzimática , Proteína Ligante Fas , Fluoresceína-5-Isotiocianato , Imunofluorescência , Genes bcl-2/genética , Humanos , Células Jurkat , Glicoproteínas de Membrana/biossíntese , Proteínas Proto-Oncogênicas/genética , Linfócitos T/metabolismo , Proteína X Associada a bcl-2 , Receptor fas/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA